Jeffrey Weitzel, MD, Oncology, Duarte, CA, City of Hope's Helford Clinical Research Hospital

JeffreyWeitzelMD

Oncology Duarte, CA

Hematologic Oncology

Professor of Oncology and Population Sciences Dr. Norman & Melinda Payson Professorship in Medical Oncology Founder, Division of Clinical Cancer Genomics City of Hope Cancer Center 1500 East Duarte Road Duarte, CA 91010

Overview of Dr. Weitzel

Dr. Jeffrey Weitzel is an oncologist in Duarte, CA and is affiliated with City of Hope's Helford Clinical Research Hospital. He received his medical degree from University of Minnesota Medical School and has been in practice 34 years. He is one of 130 doctors at City of Hope's Helford Clinical Research Hospital who specialize in Oncology.

Education & Training

  • Tufts Medical CenterFellowship, Clinical Genetics, 1994 - 1996
  • Tufts Medical CenterFellowship, Hematology/Oncology, 1987 - 1992
  • University of Minnesota at FairviewResidency, Internal Medicine, 1983 - 1986
  • University of Minnesota Medical SchoolClass of 1983

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2000 - 2015
  • CA State Medical License
    CA State Medical License 1996 - 2022
  • MN State Medical License
    MN State Medical License 1985 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Conquer Cancer Research Professorship in Breast Cancer Disparities ASCO Conquer Cancer Foundation
  • America's Top Doctors Castle Connolly, 2004-2020
  • American Society of Human Genetics Arno Motulsky-Barton Childs Award for Excellence in Human Genetics Education American Society of Human Genetics, 2019
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Finding a Germline Mutation During Tumor Testing: Implications for the Patient and the Family 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • City of Hope to Lead National Research Aimed at Improving testing/treatment for Devastating Cancer-Causing Syndrome
    City of Hope to Lead National Research Aimed at Improving testing/treatment for Devastating Cancer-Causing SyndromeNovember 22nd, 2019
  • High-Risk Multigene Test in Breast Ca Deemed Cost Effective
    High-Risk Multigene Test in Breast Ca Deemed Cost EffectiveOctober 2nd, 2019
  • Research Examines Breast Cancer Susceptibility Genes in Hispanic Women and Other Diverse Populations
    Research Examines Breast Cancer Susceptibility Genes in Hispanic Women and Other Diverse PopulationsJuly 15th, 2019
  • Join now to see all

Hospital Affiliations